- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04004052
Conservative Treatment and Ultrasound Guided Injection for Treatment Meralgia Paresthetica
Conservative Treatment Versus Ultrasound Guided Injection in Management of Meralgia Paresthetica: A Randomized Controlled Trial
Meralgia paresthetica (MP) is an entrapment mononeuropathy of the lateral femoral cutaneous nerve (LFCN), where conservative treatment options are not always sufficient.
The aim of this study was to evaluate the efficacy of ultrasound (US) guided lateral femoral cutaneous nerve injection in the management of meralgia paresthetica by comparing with transcutaneous electrical nerve stimulation (TENS) therapy and sham transcutaneous electrical nerve stimulation therapy.
Study Overview
Status
Conditions
Detailed Description
In this prospective, randomized, sham-controlled study, fifty four patients (23 female and 31 male, the mean age 53.61±11.99 years) with lateral femoral cutaneous nerve compression with clinical and electrophysiological findings were enrolled. Patients were randomly assigned to three groups: 1) Ultrasound-guided injection group, 2) TENS group, 3) Sham TENS group. The blockage of the lateral femoral cutaneous nerve was performed for therapeutic meralgia paresthetica management in group 1. Ten sessions of conventional TENS were administered to each patient 5 days a week for 2 weeks, for 20 minutes per daily session in Group 2, and sham TENS was applied to group 3 with the same protocol.
Visual Analog Scale (VAS), painDETECT questionnaire (PD-Q), Semmes Weinstein monofilament test (SWMt), Pittsburgh Sleep Quality Index (PSQI) and health-related quality of life (SF 36), at onset (T1), 15 days after treatment (T2) and 1 month after treatment (T3) were used for evaluation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria
- Patients diagnosed with LFCN entrapment confirmed by clinical and electrophysiological findings
Exclusion criteria
- Secondary entrapment neuropathy
- Malignancy
- Pregnancy
- Infection in the inguinal region or dermatitis
- Lumbar radiculopathy
- Cardiac pacemakers
- Polyneuropathy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Group 1
Blockade of the LFCN is performed for therapeutic management of MP in group 1.
|
|
Active Comparator: Group 2
Ten sessions of conventional TENS were applied to the group 2 daily 20 minutes per session, 5 days per week, for 2 weeks.
|
|
Sham Comparator: Group 3
Sham TENS was applied to the group 3 with the same protocol.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analog Scale
Time Frame: 1 months
|
The VAS was used to record each patient's current level of pain with 0 indicating no pain and 10 indicating the worst pain that the patient had ever experienced.
Using a ruler marked in centimeters, the examiner obtained the exact values along a 10-cm VAS line.
|
1 months
|
painDETECT questionnaire
Time Frame: 1 months
|
It consists of seven items evaluating pain qualities, one evaluating the course of pain, and one evaluating pain radiation.
Additionally, the questionnaire contains three numerical rating scales (NRSs) of 0-10 for current, worst, and average pain severity.
An overall score is generated that summarizes everything but the pain intensity NRS, which ranges between -1 and 38.
An overall score of >18 indicates likely Neuropathic pain, 13-18 possible Neuropathic pain, and < 13 unlikely Neuropathic pain.
|
1 months
|
Semmes-Weinstein monofilament test
Time Frame: 1 months
|
Cutaneous pressure threshold was measured by touch test using a device with nylon Semmes-Weinstein monofilaments (SWMt) embedded in a plastic handle.
A small pushing force is applied anterolateral femoral skin area for 1-1,5 seconds to push the filaments.
A medical staff member presses the filaments at an angle of approximately 90° against the patient's thigh.
This test is useful for medical staff because it is simple and easy.
The threshold was defined as the lightest filament that the subject responses correctly at least two out of the three trials.
The filaments are labeled with a numerical marking, which is a log to the base ten of the force in tenth of milligrams.
Applications was made where the most symptoms has been observed in the patient's anterolateral thigh.
|
1 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Short Form (SF-36) Health Questionnaire
Time Frame: 1 months
|
Assessment of health-related quality of life Health status was measured using the 36-Item Short Form (SF-36) Health Survey, version 2 (SF-36v2), which assesses eight different aspects of health.
Item scores can be aggregated into physical component (PC) summary and mental component (MC) summary score.
|
1 months
|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: 1 Months
|
PSQI is a 19-item self-reported instrument designed to measure a person's sleep quality and sleep patterns over 1-month time interval.
It consists of seven items evaluating sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction over the last month.
The 7 component scores are evaluated between 0 and 3 points.
3 reflects the negative extreme on the Likert Scale.
The global score ranges from 0 to 21 points.
Higher scores indicate worst sleep quality.
A global score of >5 indicates poor sleep quality.
|
1 Months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Gülcan Öztürk, MD, Fatih Sultan Training and Research Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ozturk84
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Meralgia Paresthetica
-
Mersin Training and Research HospitalCompleted
-
University of AlexandriaCompleted
-
Canadian Forces Health Services Centre OttawaCompletedMeralgia Paresthetica
-
Peking University People's HospitalCompletedMeralgia ParestheticaChina
-
October 6 UniversityCompletedFemoral Neuropathy | Meralgia ParestheticaEgypt
-
Ahram Canadian UniversityRecruitingMeralgia Paresthetica | Lateral Femoral Cutaneous Nerve EntrapmentEgypt
-
Johns Hopkins UniversityBTG International Inc.WithdrawnLow Back Pain | Groin Pain | Pelvic Pain Syndrome | Meralgia Paresthetica | Perineal NeuralgiaUnited States
-
Innovaderm Research Inc.Merz Pharmaceuticals GmbHCompleted
-
Cara Therapeutics, Inc.CompletedPruritus | Notalgia ParestheticaUnited States, Canada
-
Cara Therapeutics, Inc.RecruitingPruritus | Notalgia ParestheticaUnited States, Poland, Spain, Canada, Germany
Clinical Trials on Ultrasound guided injection
-
Tri-Service General HospitalCompleted
-
National Taiwan University HospitalNot yet recruiting
-
Northumbria Healthcare NHS Foundation TrustCompletedGreater Trochanteric Pain SyndromeUnited Kingdom
-
Mansoura UniversityCompleted
-
Stanford UniversityNYU Langone HealthCompletedTendinopathyUnited States
-
Rigshospitalet, DenmarkCompletedMusculoskeletal DiseasesDenmark
-
Cairo UniversityRecruitingTemporomandibular Joint DislocationEgypt
-
Diskapi Teaching and Research HospitalCompleted
-
Tri-Service General HospitalCompletedCarpal Tunnel SyndromeTaiwan
-
Ohio State UniversityWithdrawnKnee Pain Chronic | Pes Anserinus Bursitis | Status-Post Total Knee ArthroplastyUnited States